These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 28353226)
1. Proteomic Biomarker Identification in Cerebrospinal Fluid for Leptomeningeal Metastases with Neurological Complications. Galicia N; Díez P; Dégano RM; Guest PC; Ibarrola N; Fuentes M Adv Exp Med Biol; 2017; 974():85-96. PubMed ID: 28353226 [TBL] [Abstract][Full Text] [Related]
2. CSF analysis for protein biomarker identification in patients with leptomeningeal metastases from CNS lymphoma. Galicia N; Dégano R; Díez P; González-González M; Góngora R; Ibarrola N; Fuentes M Expert Rev Proteomics; 2017 Apr; 14(4):363-372. PubMed ID: 28293970 [TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid tumour markers in patients treated for meningeal malignancy. van Zanten AP; Twijnstra A; Ongerboer de Visser BW; van Heerde P; Hart AA; Nooyen WJ J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):119-23. PubMed ID: 2019836 [TBL] [Abstract][Full Text] [Related]
4. Creatine kinase-BB in the cerebrospinal fluid as a marker of CNS metastases and leptomeningeal carcinomatosis in patients with breast cancer. Bach F; Bach FW; Pedersen AG; Larsen PM; Dombernowsky P Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1703-9. PubMed ID: 2632253 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis. Zhang Z; Tian C; Shi Q; Hao J; Zhao N; Liu Z Dis Markers; 2017; 2017():2467870. PubMed ID: 28298807 [TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid neopterin levels in children with central nervous system leukemia. Millot F; Dhondt JL; Mazingue F; Mechinaud F; Auget JL; Bauters F; Harousseau JL Leuk Lymphoma; 1993 Mar; 9(4-5):351-6. PubMed ID: 8348070 [TBL] [Abstract][Full Text] [Related]
7. HMFG1 antigen: a new marker for carcinomatous meningitis. Moseley RP; Oge K; Shafqat S; Moseley CM; Sullivan NM; Badley RA; Burchell J; Taylor-Papadimitriou J; Coakham HB Int J Cancer; 1989 Sep; 44(3):440-4. PubMed ID: 2777410 [TBL] [Abstract][Full Text] [Related]
8. Leptomeningeal carcinomatosis and cranial nerve palsy as presenting symptoms of a clinically inapparent gallbladder carcinoma. Gaumann A; Marx J; Bohl J; Kommoss F; Köhler H; Tews DS Pathol Res Pract; 1999; 195(7):495-9. PubMed ID: 10448666 [TBL] [Abstract][Full Text] [Related]
9. CSF levels of angiogenesis-related proteins in patients with leptomeningeal metastases. Groves MD Neurology; 2006 May; 66(10):1609-10; author reply 1609-10. PubMed ID: 16717241 [No Abstract] [Full Text] [Related]
11. Gastric cancer with isolated leptomeningeal metastases: a case report. Sambasivaiah K; Reddy K; Lakshmi AY; Menon B; Varma VS Trop Gastroenterol; 2007; 28(1):39-40. PubMed ID: 17896611 [TBL] [Abstract][Full Text] [Related]
12. CSF protein profiling using Multiplex Immuno-assay: A potential new diagnostic tool for leptomeningeal metastases. Brandsma D; Voest EE; de Jager W; Bonfrer H; Algra A; Boogerd W; Korse T; Reijneveld JC; Verbeek MM; Rijkers G; Taphoorn MJ J Neurol; 2006 Sep; 253(9):1177-84. PubMed ID: 16998648 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies. Schmid D; Warnken U; Latzer P; Hoffmann DC; Roth J; Kutschmann S; Jaschonek H; Rübmann P; Foltyn M; Vollmuth P; Winkler F; Seliger C; Felix M; Sahm F; Haas J; Reuss D; Bendszus M; Wildemann B; von Deimling A; Wick W; Kessler T J Neurochem; 2021 Jul; 158(2):522-538. PubMed ID: 33735443 [TBL] [Abstract][Full Text] [Related]
14. [Meningeal carcinomatosis]. Baiges-Octavio JJ; Huerta-Villanueva M Rev Neurol; 2000 Dec 16-31; 31(12):1237-41. PubMed ID: 11205566 [TBL] [Abstract][Full Text] [Related]
15. Identification of leptomeningeal metastasis-related proteins in cerebrospinal fluid of patients with breast cancer by a combination of MALDI-TOF, MALDI-FTICR and nanoLC-FTICR MS. Römpp A; Dekker L; Taban I; Jenster G; Boogerd W; Bonfrer H; Spengler B; Heeren R; Smitt PS; Luider TM Proteomics; 2007 Feb; 7(3):474-81. PubMed ID: 17274072 [TBL] [Abstract][Full Text] [Related]
16. Leptomeningeal metastasis from prostate cancer. Cante D; Franco P; Sciacero P; Girelli G; Casanova Borca V; Pasquino M; Migliaccio F; Tofani S; Grassi L; Marra A; Ozzello F; La Porta MR; Ricardi U Tumori; 2013; 99(1):6e-10e. PubMed ID: 23549020 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of the cerebrospinal fluid for carcinomatous and lymphomatous leptomeningitis. Hovestadt A; Henzen-Logmans SC; Vecht CJ Br J Cancer; 1990 Oct; 62(4):653-4. PubMed ID: 2223585 [TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors. Lin X; Fleisher M; Rosenblum M; Lin O; Boire A; Briggs S; Bensman Y; Hurtado B; Shagabayeva L; DeAngelis LM; Panageas KS; Omuro A; Pentsova EI Neuro Oncol; 2017 Sep; 19(9):1248-1254. PubMed ID: 28821205 [TBL] [Abstract][Full Text] [Related]
19. Tissue polypeptide antigen activity in cerebrospinal fluid: a marker of central nervous system metastases of breast cancer. Bach F; Soletormos G; Dombernowsky P J Natl Cancer Inst; 1991 Jun; 83(11):779-84. PubMed ID: 2041052 [TBL] [Abstract][Full Text] [Related]
20. Untargeted metabolomics analysis of cerebrospinal fluid in patients with leptomeningeal metastases from non-small cell lung cancer. Li H; Lin Y; Zheng S; Yu T; Xie Y; Yin Z Biotechnol Genet Eng Rev; 2024 Oct; 40(2):815-832. PubMed ID: 36942709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]